SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Dr. Mrinal Kammili
With over 27 years of experience spanning healthcare, pharmaceuticals, clinical research, and life sciences, Mrinal brings a wealth of expertise to his role as Head of Translational and Clinical Research. A medical doctor and AHA-certified intensivist, Mrinal transitioned into these fields following a senior residency in cardiology.
Currently he is pursuing a certificate in Health Care Management from the Indian School of Business (ISB). Mrinal specializes in corporate strategy, business development, and operational excellence.